JUSTIN ROCHA: Open Payments
NPI 1649942517 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 34 payments from 15 companies in 2025. Trend: 2023 $253 · 2024 $201 · 2025 $675
Food & beverage: $628Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Lilly USA, LLC | 2 | $71 |
| Corcept Therapeutics | 4 | $68 |
| Novo Nordisk Inc | 3 | $56 |
| Amphastar Pharmaceuticals, Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 1 | $32 |
| Organon LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VRAYLAR, Korlym, Ozempic, BREZTRI, VOQUEZNA, NEXPLANON, MOUNJARO, AIRSUPRA.
Industry payments across OR — which companies pay providers there.
